US Bancorp DE Has $159,000 Stake in Simulations Plus, Inc. (NASDAQ:SLP)

US Bancorp DE boosted its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 14.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,687 shares of the technology company’s stock after buying an additional 713 shares during the period. US Bancorp DE’s holdings in Simulations Plus were worth $159,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Illumine Investment Management LLC bought a new position in shares of Simulations Plus in the fourth quarter worth about $280,000. Proficio Capital Partners LLC acquired a new stake in Simulations Plus during the 4th quarter worth approximately $719,000. Olympiad Research LP bought a new stake in Simulations Plus during the 4th quarter worth approximately $211,000. Rice Hall James & Associates LLC increased its position in Simulations Plus by 19.4% in the 4th quarter. Rice Hall James & Associates LLC now owns 91,500 shares of the technology company’s stock valued at $2,552,000 after acquiring an additional 14,871 shares during the period. Finally, Principal Financial Group Inc. raised its stake in shares of Simulations Plus by 4.5% during the fourth quarter. Principal Financial Group Inc. now owns 91,177 shares of the technology company’s stock valued at $2,543,000 after acquiring an additional 3,904 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SLP has been the subject of several analyst reports. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. KeyCorp raised their price target on shares of Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Simulations Plus currently has a consensus rating of “Moderate Buy” and a consensus target price of $49.40.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the sale, the director now directly owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 19.40% of the company’s stock.

Simulations Plus Stock Up 2.8 %

Shares of NASDAQ SLP opened at $26.08 on Friday. The company has a market capitalization of $524.00 million, a PE ratio of 65.20 and a beta of 0.89. The firm has a fifty day simple moving average of $31.63 and a 200 day simple moving average of $31.25. Simulations Plus, Inc. has a twelve month low of $24.00 and a twelve month high of $51.22.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.